Yiyu Cheng

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Real-World Efficacy and Safety of Adalimumab Biosimilar (HS016) in Biologic-Naïve Patients with Perianal Fistulizing Crohn's Disease: A Prospective, Single-Arm, Observational Study.

Real-World Efficacy and Safety of Adalimumab Biosimilar (HS016) in Biologic-Naïve Patients with Perianal Fistulizing Crohn's Disease: A Prospective, Single-Arm, Observational Study.

Journal: Drug design, development and therapy

Published: October 16, 2025

Insights into the treatment of infliximab and vedolizumab in positive PR3-ANCA patients with moderately to severely active ulcerative colitis: multicenter real-world evidence.

Insights into the treatment of infliximab and vedolizumab in positive PR3-ANCA patients with moderately to severely active ulcerative colitis: multicenter real-world evidence.

Journal: BMC gastroenterology

Published: July 01, 2025

Upadacitinib induction therapy in Crohn' s disease: a retrospective real-world study in biologic-refractory patients.

Upadacitinib induction therapy in Crohn' s disease: a retrospective real-world study in biologic-refractory patients.

Journal: BMC gastroenterology

Published: June 04, 2025

Rituximab in PR3-ANCA positive patients with moderately to severely active ulcerative colitis: a multicenter real-world pilot study.

Rituximab in PR3-ANCA positive patients with moderately to severely active ulcerative colitis: a multicenter real-world pilot study.

Journal: Frontiers in pharmacology

Published: May 01, 2025

The value of fecal calprotectin measured by fluorescent immunochromatography assay in evaluating clinical and endoscopic activity in ulcerative colitis.

The value of fecal calprotectin measured by fluorescent immunochromatography assay in evaluating clinical and endoscopic activity in ulcerative colitis.

Journal: BMC gastroenterology

Published: February 16, 2025

Estrogen receptor β alleviates colitis in intestinal epithelial cells and activates HIF-1a and ATG-9a-mediated autophagy.

Estrogen receptor β alleviates colitis in intestinal epithelial cells and activates HIF-1a and ATG-9a-mediated autophagy.

Journal: Experimental cell research

Published: October 22, 2024

Estrogen Receptor β Alleviates Colitis by Inhibiting Ferroptosis in Intestinal Epithelial Cells.

Estrogen Receptor β Alleviates Colitis by Inhibiting Ferroptosis in Intestinal Epithelial Cells.

Journal: Journal of inflammation research

Published: September 22, 2024

Mesenteric adipose-derived exosomal TINAGL1 enhances intestinal fibrosis in Crohn's Disease via SMAD4.

Mesenteric adipose-derived exosomal TINAGL1 enhances intestinal fibrosis in Crohn's Disease via SMAD4.

Journal: Journal of advanced research

Published: February 04, 2024

Uncovering the Novel Role of NR1D1 in Regulating BNIP3-Mediated Mitophagy in Ulcerative Colitis.

Uncovering the Novel Role of NR1D1 in Regulating BNIP3-Mediated Mitophagy in Ulcerative Colitis.

Journal: International journal of molecular sciences

Published: August 08, 2023

An updated review of gastrointestinal toxicity induced by PD-1 inhibitors: from mechanisms to management.

An updated review of gastrointestinal toxicity induced by PD-1 inhibitors: from mechanisms to management.

Journal: Frontiers in immunology

Published: March 21, 2023

Oat beta-glucan reduces colitis by promoting autophagy flux in intestinal epithelial cells via EPHB6-TFEB axis.

Oat beta-glucan reduces colitis by promoting autophagy flux in intestinal epithelial cells via EPHB6-TFEB axis.

Journal: Frontiers in pharmacology

Published: March 18, 2023

Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn's disease.

Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn's disease.

Journal: Frontiers in physiology

Published: March 15, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026